Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Woebot for Substance Use Disorders Phase 2 RCT: Digitally Delivered Intervention for Reducing Problematic Substance Use

NCT04925570 is registered in ClinicalTrials.gov with Woebot Health as lead sponsor.

NCT NCT04925570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04925570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Woebot for Substance Use Disorders Phase 2 RCT: Digitally Delivered Intervention for Reducing Problematic Substance Use
Lead sponsor
Woebot Health
Phase
Phase 2
Overall status
Completed
Start date
November 14, 2022
Completion date
August 17, 2023
Enrollment
258 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud), substance use disorders